Interest and Impact of Skin Cancer Genetic Testing

Memorial Sloan Kettering Cancer Center (MSK)

Status: Completed

Conditions: Non-melanoma Skin Cancer (NMSC)

Treatments: Genetic: MC1R genotyping; Behavioral: Baseline Survey; Behavioral: MC1R Testing Website

Study type: Observational

Funder types: Other

Identifiers

NCT02941900

16-1243

Details and patient eligibility

About

The purpose of this study is to learn whether the patient might be interested in skin cancer genetic testing, and if so, what kinds of thoughts, feelings, and behaviors might result from this testing. Testing for skin cancer risk based on the MC1R gene is not currently used in clinical practice; it will be offered in this study for research purposes only.

Enrollment: 53 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• 18 years of age or older
• English fluent as we do not have the resources to translate all the materials including the website and risk feedback materials into other languages
• Prior history of stage 0, I or II NMSC as per EMR or clinical judgment

Exclusion criteria

• Inability to provide meaningful informed consent due to cognitive or psychiatric disability as determined by the judgement of the consenting professional or clinician

Trial design

53 participants in 1 patient group

Non-melanoma skin cancers (NMSCs)

Treatment:

Behavioral: Baseline Survey

Genetic: MC1R genotyping

Behavioral: MC1R Testing Website